COMMUNIQUÉS West-GlobeNewswire

International Stem Cell Corporation is Valued at $33 Million Market Value by Edison Investment Research

22/01/2018 - 14:30

CARLSBAD, Calif., Jan. 22, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based [...]

Lotus Ventures – Closing of Cannabis Financing of $5 Million; Solidifying Expansion Capital

22/01/2018 - 14:30

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 22, 2018 (GLOBE NEWSWIRE) -- The Company has closed its financing for gross proceeds of $5,018, [...]

Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania

22/01/2018 - 14:27

NEW HAVEN, Conn., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc . (NASDAQ: PRPO ), today announced it is collaborating with the cytogenetics laboratory at the University of Pennsylvania to [...]

United Health Products Issues FDA Update

22/01/2018 - 14:15

HENDERSON, Nev., Jan. 22, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTCPK:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]

Inovio Pharmaceuticals' Published Universal Flu Vaccine Data Demonstrates Protective Responses Against All Major, Lethal H1N1 Influenza Viruses From the Last 100 Years in Animal Models

22/01/2018 - 14:00

PLYMOUTH MEETING, Pa., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that Inovio’s synthetic vaccine approach using a collection of synthetic DNA antigens generated broad [...]

PetMed Express D/B/A 1-800-PetMeds Announces Its Third Quarter Financial Results and Increased Its Quarterly Dividend by 25% to $0.25 per Share

22/01/2018 - 14:00

Third Quarter New Order Sales Increased 15.5% Third Quarter Net Income Increased 88% Third Quarter Sales Increased 13.7% DELRAY BEACH, Fla., Jan. 22, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS ) today [...]

Sorrento Therapeutics to Present at Noble Capital Markets’ Fourteenth Annual Investor Conference on 01/29/18

22/01/2018 - 14:00

SAN DIEGO, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it will present at NobleCon14 - Noble Capital Markets’ Fourteenth Annual Investor Conference at [...]

Altimmune to Participate at the Noble Capital 14th Annual Investor Conference

22/01/2018 - 14:00

GAITHERSBURG, Md., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, will provide a [...]

Encouraging Early Safety and Efficacy Data in Cynata’s Phase 1 Trial of CYP-001 in GvHD; DSMB Recommendation to Initiate Enrolment of Second Patient Cohort

22/01/2018 - 14:00

MELBOURNE, Australia, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP) is pleased to announce that the independent Data Safety Monitoring [...]

PositiveID Corporation Announces Lawrence Livermore National Laboratory Evaluation of PositiveID’s FireflyDX

22/01/2018 - 14:00

DELRAY BEACH, Fla., Jan. 22, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, and its ExcitePCR Corporation subsidiary, announced today that [...]

Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender Offer

22/01/2018 - 14:00

SAINT-GENIS-POUILLY, France, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ: AAAP ) (“AAA” or the “Company”), a leader in nuclear medicine theragnostics, today announced that a [...]

AIT Therapeutics Announces Further Data From Its NO-NTM Abscessus Phase 2 Clinical Trial in Nontuberculous Mycobacteria (NTM) Patients

22/01/2018 - 14:00

Mycobacterium Abscessus Load Reduced by 65% 6-Minute Walk Improvement Maintained at Day 81 NEW YORK, Jan. 22, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused [...]

Rexahn Pharmaceuticals Announces Poster Presentation of RX-3117 Data in Metastatic Pancreatic Patients at the American Society of Clinical Oncology Gastrointestinal Cancers (ASCO GI) 2018 Annual Meeting

22/01/2018 - 13:30

Encouraging Progression Free Survival and Evidence of Tumor Shrinkage Observed in Patients with Metastatic Pancreatic Cancer Resistant to Gemcitabine who had Failed on Multiple Prior Treatments Rexahn is Progressing [...]

Athenex, Inc. Announces Proposed Offering of Common Stock

22/01/2018 - 13:10

BUFFALO, N.Y., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Athenex (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer [...]

Myriad Applauds New Consensus Statement From International Expert Panel On Screening Recommendations for Hereditary Prostate Cancer

22/01/2018 - 13:05

SALT LAKE CITY, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, announced today that the company is applauding a new consensus [...]

Shire to Present Data on Short Bowel Syndrome With Intestinal Failure at the ASPEN 2018 Nutrition Science & Practice Conference

22/01/2018 - 13:00

Shire to Present Data on Short Bowel Syndrome With Intestinal Failure at the ASPEN 2018 Nutrition Science & Practice Conference Cambridge, Mass. - January 22, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG), the global [...]

Athenex Announces Encouraging Early Clinical Efficacy and Safety Data of Oraxol in Clinical Trial for the Treatment of Breast Cancer

22/01/2018 - 13:00

BUFFALO, N.Y., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Athenex (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer [...]

Endonovo Announces First Commercial Sales for SofPulse Wearable Electroceutical for Post-Operative Pain and Edema

22/01/2018 - 13:00

Seeking Distribution Partners in Europe for CE-Marked Electroceutical™ Device for Promotion of Wound Healing, Reduction of Pain and Post-Operative Edema LOS ANGELES, CA, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Endonovo [...]

IRADIMED CORPORATION Announces 2018 Annual and First Quarter Financial Guidance

22/01/2018 - 13:00

Announces Preliminary Full Year and Fourth Quarter 2017 Revenue Announces Fourth Quarter 2017 Financial Results Conference Call Date WINTER SPRINGS, Fla., Jan. 22, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: [...]